FranklinLChenMD

Hematologic Oncology

Clinical Physician Executive, Department of Hematology Oncology, Transplant Cellular Therapy Section, Novant Health Cancer Institute

Join to view full profile

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Chen's full profile

Already have an account?

Office
3333 Silas Creek Pkwy
Winston Salem, NC 27103
Phone+1 336-277-8800

Fax+1 336-277-8850
Is this information wrong?

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
UPMC Medical EducationResidency, Internal Medicine, 2003 - 2006
Icahn School of Medicine at Mount SinaiClass of 2003

Certifications & Licensure

NC State Medical License 2006 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread Start of enrollment: 2014 Mar 12
Active, not recruiting
Phase 2
Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL Start of enrollment: 2022 Jan 01
Withdrawn
Phase 2

Publications & Presentations

PubMed

The effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation.
Jan S Moreb, Lori Lantos, Franklin Chen, Kathleen Elliott, James Dugan, Alan P Skarbnik, Patricia Lamont Kropf, Kimberly Ward> ;Transfusion and Apheresis Science. 2023 Dec 1
14 citations
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
Claire F. Verschraegen, Guy Jerusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern, Jaafar Bennouna, Franklin Chen, Karen Kelly, Janice M. Mehnert, John C....> ;Journal for Immunotherapy of Cancer. 2020 Sep 1
125 citations
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Raffit Hassan, Anish Thomas, John Nemunaitis, Manish R. Patel, Jaafar Bennouna, Franklin Chen, Jean Pierre Delord, Afshin Dowlati, Samith T. Kochuparambil, Matthew H. ...> ;JAMA Oncology. 2019 Mar 1
41 citations
Resistance to ErbB2 Tyrosine Kinase Inhibitors in Breast Cancer Is Mediated by Calcium-Dependent Activation of RelA
Wenle Xia, Sarah S. Bacus, Intisar Husain, Leihua Liu, Sumin Zhao, Zuguo Liu, M. Arthur Moseley, J. Will Thompson, Franklin L. Chen, Kevin M. Koch, Neil L. Spector> ;Molecular Cancer Therapeutics. 2010 Feb 1
87 citations
Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors
Franklin L. Chen, Wenle Xia, Neil L. Spector> ;Clinical Cancer Research. 2008 Nov 1
7 citations
Cell signaling modifiers in prostate cancer.
Franklin L. Chen, Andrew J. Armstrong, Daniel J. George> ;Cancer Journal. 2008 Jan 1
31 citations
Focal gap junction uncoupling and spontaneous ventricular ectopy.
David E. Gutstein, Stephan B. Danik, Steve Lewitton, Fangyu Liu, Franklin L. Chen, Jie Zhang, Newsha Ghodsi, Gregory E. Morley, Glenn I. Fishman> ;American Journal of Physiology. Heart and Circulatory Physiology. 2005 Sep 1
138 citations
Heterogeneous Expression of Gap Junction Channels in the Heart Leads to Conduction Defects and Ventricular Dysfunction
David E. Gutstein, Gregory E. Morley, Dhananjay Vaidya, Fangyu Liu, Franklin L. Chen, Heidi Stuhlmann, Glenn I. Fishman> ;Circulation. 2001 Sep 4
Join now to see all